- The evidence suggests that cognitive assessment tools that are completed by people themselves could be used in the detection and diagnosis of dementia. - There is not enough evidence to recommend ...

Agreement Reached on Primary Endpoint and Phase 3 Trial Design. Oral APX3330 is a Late-Stage Clinical Asset Available for Partnering. FARMINGTON HILLS, Mich., Dec. 19, 2024 (GLOBE ...